Oragenics Inc (OGEN)

0.6197 -0.04  -6.11% NYSE AM Sep 24, 20:00 USD
View Full Chart
Price Chart
View All Events


Date Type Description
11/16/2020 Earnings Oragenics Inc Third Quarter Earnings Results for 2020
08/21/2020 09:00 EDT Misc Oragenics Inc Annual General Meeting for 2019
08/14/2020 Earnings Oragenics Inc Second Quarter Earnings Results for 2020
05/15/2020 Earnings Oragenics Inc First Quarter Earnings Results for 2020
03/11/2020 Misc Oragenics Inc Annual Report for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • URL: https://www.oragenics.com
  • Investor Relations URL: http://www.oragenics.com/?q=investors
  • HQ State/Province: Florida
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Nov. 16, 2020
  • Last Earnings Release: Aug. 14, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Oragenics Inc is engaged in the healthcare sector. The firm is focused on becoming a leader in developing novel antibiotics against infectious disease and on developing effective treatments for oral mucositis. Oragenics involves developing its antibiotic product candidate, OG716 as well as other homolog antibiotic product candidates, researching LBPs, and have other product candidates, including SMaRT Replacement Therapy positioned for out-licensing or partnering.





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.